Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid.
Freire PC, Muñoz CH, Derhaschnig U, Schoergenhofer C, Firbas C, Parry GC, Panicker S, Gilbert JC, Stingl G, Jilma B, Heil PM. Freire PC, et al. Among authors: heil pm. J Invest Dermatol. 2019 Dec;139(12):2417-2424.e2. doi: 10.1016/j.jid.2019.04.025. Epub 2019 Jun 20. J Invest Dermatol. 2019. PMID: 31229501 Free article. Clinical Trial.
COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report.
Anderle K, Machold K, Kiener HP, Bormann D, Hoetzenecker K, Geleff S, Prosch H, Laccone F, Heil PM, Petzelbauer P, Aletaha D, Blüml S, Kastrati K. Anderle K, et al. Among authors: heil pm. BMC Rheumatol. 2022 Jul 13;6(1):42. doi: 10.1186/s41927-022-00271-1. BMC Rheumatol. 2022. PMID: 35821079 Free PMC article.
Cutaneous ulceration as primary presentation of TEMPI syndrome.
Strobl J, Sinz C, Heil PM, Stary G, Weninger W. Strobl J, et al. Among authors: heil pm. J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e891-e894. doi: 10.1111/jdv.17539. Epub 2021 Aug 4. J Eur Acad Dermatol Venereol. 2021. PMID: 34310769 No abstract available.
Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients.
Reiberger T, Payer BA, Kosi L, Heil PM, Rieger A, Peck-Radosavljevic M; Vienna HIV Coinfection Study Group. Reiberger T, et al. Among authors: heil pm. J Infect Dis. 2011 Jun 15;203(12):1802-6. doi: 10.1093/infdis/jir194. J Infect Dis. 2011. PMID: 21606538
17 results